Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Withdrawal risk during a recession can threaten income stability. This overview highlights risk factors and straightforward mitigation approaches.
26,857 articlesBoxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
A disciplined move by a major crypto investor shows how a sizable cash cushion can coexist with growing BTC exposure....
Investors face a choice between a pharmaceutical powerhouse with proven earnings and a high-growth space company unde...
A sharp drop in Oddity Tech shares sparked questions about the health of a high-growth tech play. Even with solid qua...
Midweek headlines can turn crypto markets on a dime. This piece explains the drivers behind bitcoin sinking wednesday...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Investors are buzzing about Avalanche. Could avalanche about have biggest spark this year? Here’s how the platform wo...
SpaceX's IPO excitement gave way to a pullback, leaving investors wondering about future gains. This guide breaks dow...
When high-profile investors tilt toward value, curious readers take note. This piece breaks down why billionaire Bill...
Small modular reactors could redefine electricity costs and energy security. This guide breaks down the investment th...
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
Fox stock is down after announcing a Roku deal, leaving investors weighing value vs risk. This guide breaks down the ...